Tylenol is owned by Kenvue (the United States, NYSE: KVUE), which was separated from Johnson & Johnson on 23 August 2023.[1][2] Before Kenvue, Tylenol was owned by Johnson & Johnson from 1959 to 2023.[2]
Tylenol is an acetaminophen pain reliever launched in 1955 and sold as an aspirin alternative for people who could not tolerate it. Seven deaths from cyanide-laced capsules in Chicago in 1982 led to the recall of 31 million bottles and produced the tamper-evident packaging now standard across the industry.
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Kenvue ownership tree →
Kimberly-Clark agreed to acquire Kenvue in a cash and stock transaction that would combine Huggies and Kleenex with Tylenol, Listerine and Neutrogena. The deal is subject to shareholder and regulatory approvals.
Johnson & Johnson separated its consumer health business as Kenvue, which listed in May 2023 and was fully split off through an exchange offer completed on 23 August 2023. Tylenol, Band-Aid, Listerine, Neutrogena and Johnson's Baby all moved to the new company.
No tagged news items yet. Headlines are added nightly from public feeds; only titles and links are stored.
Headlines link to the original publisher. Brandtree does not reproduce article text.
The parent company of Tylenol is Kenvue, a publicly listed company headquartered in the United States.
Yes. Tylenol originated in the United States in 1955 and its owner, Kenvue, is also headquartered in the United States.
Kenvue has owned Tylenol since 23 August 2023.
Before Kenvue, Tylenol was owned by Johnson & Johnson from 1959 until 2023.
Yes. As of 6 September 2026, Tylenol is still owned by Kenvue. The ownership record was last checked against primary sources on that date.
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.